Biomarin Pharmaceutical Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Okay. Good morning, everyone. From the virtual JPMorgan Healthcare Conference. My name is Cory Kasimov, I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company, BioMarin. As you can see on your screens here, we have quite the contingent. So in addition to J.J. Bienaime, the Chairman and CEO; Hank Fuchs, President of Worldwide Research and development; Jeff Ajer, Executive Vice President and Chief Commercial Officer; Greg Guyer, Executive Vice President and Chief Technical Officer; Brian Mueller, EVP and Chief Financial Officer; and Lon Cardon, SVP and Chief Scientific Strategy Officer.
So they'll all be here for Q&A in addition to some of the slides towards the end. (Operator Instructions)
So with that, J.J., thank you for being here today. Let me hand things off to you.
Thank you, Cory. Good morning or good afternoon,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |